Cervical Cancer: Staging and Surgical Management

Clinical Note: While SLN mapping is highly effective for tumors $<2$ cm, it can be applied to larger tumors ($2$ cm to $4$ cm) provided there is strict adherence to established NCCN algorithms.

Surgical Management Strategies

Surgical intervention is tailored to the tumor's stage and the patient's desire for fertility preservation. The choice of procedure is a delicate balance between achieving clear margins and maintaining reproductive function.

Fertility-Sparing Surgery

For patients with low-risk, early-stage cancers—specifically Stage IA1 (without lymphovascular space invasion) or small IB1 adenocarcinomas—conservative approaches are prioritized.

1. Conization: This may be performed via Loop Electrosurgical Excision Procedure (LEEP) or cold knife conization. A critical requirement for conservative management is achieving at least a 1-mm negative margin.
2. Radical Trachelectomy: For more advanced early-stage cases (e.g., Stage IB1 or select IB2), a radical trachelectomy—which can be performed via abdominal, vaginal, or laparoscopic routes—allows for the preservation of the uterine body while removing the cervix.

Radical Hysterectomy

When fertility preservation is not the goal or is not clinically appropriate, radical hysterectomy is the standard of care. These procedures are classified using the Querleu-Morrow system, which provides a standardized anatomical template for parametrial resection.

• Type A Hysterectomy: Often used for Stage IA1 with lymphovascular space invasion (LVSI).
• Type B Radical Hysterectomy: Utilized when margins are positive for carcinoma in certain early stages.

Surgical Modalities and Outcomes

The method of delivery—whether open or minimally invasive—has significant implications for recovery and, potentially, long-term survival.

Minimally Invasive Surgery (MIS)

There is ongoing research comparing laparoscopic and robotic-assisted radical hysterectomies against traditional open (laparotomy) approaches. It is important for clinicians to note the findings of the LACC Trial, which highlighted critical comparative effectiveness and survival outcomes between MIS and open approaches in certain patient populations.

Advanced and Recurrent Disease

For patients presenting with highly advanced or recurrent disease, more extensive procedures such as pelvic exenteration may be considered to achieve local control.

Summary of Clinical Pathways

The following table summarizes the primary treatment pathways for common stages:

Exam Tip: Always check for Lymphovascular Space Invasion (LVSI). The presence of LVSI often shifts the recommendation from simple conservative surgery to more aggressive staging or radical procedures.

---

References

• NCCN Guidelines Version 1.2027, Cervical Cancer. October 15, 2026.